Guru Ownership Trend
Guru Analysis for Iovance Biotherapeutics, Inc. (IOVA)
Iovance Biotherapeutics, Inc. (IOVA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $58.08 M.
Top institutional holders include Cliff Asness and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $13.83 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 520.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Iovance Biotherapeutics, Inc. (IOVA)
Major holders include Cliff Asness ($16.1 M), Paul Tudor Jones ($1.22 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 4.16 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $13.83 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in IOVA during the most recent reporting period.
Yes, 0 managers opened new positions in IOVA, and 2 increased their existing holdings. The total reported buy value was $13.83 M.